OptimizeRx Q2 GAAP net loss narrows to $0.7 million; revenue drops 30% to $20.5 million year over year - OPRX News | RalliesOptimizeRx Q2 GAAP net loss narrows to $0.7 million; revenue drops 30% to $20.5 million year over year
O
OPRX• Q2 results and guidance
- OptimizeRx Q2 2026 revenue fell 30% to $20.5 million year over year.
- GAAP results swung to a net loss of $0.7 million, while adjusted EBITDA slipped to $4.9 million.
- Cash totaled $24.1 million at June 30, 2026; the company completed debt refinancing with a $35 million facility, including a $25 million term loan.
- CEO Stephen L. Silvestro said revenue pressure was concentrated among a small number of customers, with increased investment elsewhere in the base.
- The company reaffirmed fiscal 2026 guidance for revenue of $95 million to $100 million; adjusted EBITDA is seen at $21 million to $25 million.
NKSH
•
